Skip to Content

WATSON 3546 (Aspirin, Butalbital, Caffeine and Codeine 325 mg / 50 mg / 40 mg / 30 mg)

Pill with imprint WATSON 3546 is Blue & Yellow, Capsule-shape and has been identified as Aspirin, Butalbital, Caffeine and Codeine 325 mg / 50 mg / 40 mg / 30 mg. It is supplied by Watson Pharmaceuticals.

Aspirin/butalbital/caffeine/codeine is used in the treatment of headache and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine/codeine 325 mg / 50 mg / 40 mg / 30 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 3546

Aspirin, Butalbital, Caffeine and Codeine

Imprint
WATSON 3546
Strength
325 mg / 50 mg / 40 mg / 30 mg
Color
Blue & Yellow
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-3546
Inactive Ingredients
microcrystalline cellulose, corn starch, magnesium silicate, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 3, FD&C Yellow No. 6, gelatin, titanium dioxide, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.